In gastric cancer, dysregulated miRNAs have been identified as being partly responsible for malignant processes, including drug resistance, depending on the aberrantly activated PI3K pathway, normally controlled by miRNAs [78]. The gene discussed is PIK3CA; the disease is gastric cancer.